Literature DB >> 31304776

circ_0001730 promotes proliferation and invasion via the miR-326/Wnt7B axis in glioma cells.

Yaoyong Lu1, Xubin Deng2, Guanghui Xiao3, Xin Zheng4, Lei Ma2, Wendong Huang5.   

Abstract

Aim: To study the role of circRNA (circ_0001730) in glioblastoma. Materials & methods: The interaction between circ_0001730 and miR-326 was confirmed by FISH, RNA pull down, RNA-binding protein immunoprecipitation and luciferase reporter assays. Cell proliferation and growth were determined by MTT, EdU and colony formation assays. Cell migration was assessed by the Boyden assay.
Results: The levels of circ_0001730 were elevated in glioblastoma cell lines and tissues. circ_0001730 downregulation suppressed migration and proliferation in glioblastoma cells. SP1 bounds to the promoter of circ_0001730 host gene EPHB4 thereby increasing the expression of circ_0001730. circ_0001730 activated the Wnt/β-catenin pathway via the miR-326/Wnt7B axis.
Conclusion: circ_000173 promoted growth and invasion in glioblastoma cells via the miR-326/Wnt7B axis.

Entities:  

Keywords:  Wnt7B; circRNAs; epithelial to mesenchymal transition; glioblastoma; miR-326; β-catenin

Mesh:

Substances:

Year:  2019        PMID: 31304776     DOI: 10.2217/epi-2019-0121

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  16 in total

1.  Circ_0007534 Silencing Inhibits the Proliferation, Migration and Invasion and Induces the Apoptosis of Glioma Cells Partly Through Down-Regulating PROX1 Via Elevating miR-22-3p Level.

Authors:  Yong Zheng; Yan Wang; Rongkang Mai; Liang Liu; Zifeng Zhu; Yiyao Cao
Journal:  Cell Mol Neurobiol       Date:  2021-09-18       Impact factor: 4.231

2.  Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis.

Authors:  Tuo Wang; Ping Mao; Yong Feng; Bo Cui; Bin Zhang; Chen Chen; Mingjie Xu; Ke Gao
Journal:  Cell Cycle       Date:  2021-05-24       Impact factor: 5.173

3.  CircRNA ZNF609 Knockdown Suppresses Cell Growth via Modulating miR-188/ELF2 Axis in Nasopharyngeal Carcinoma.

Authors:  Mingyan Li; Yujie Li; Min Yu
Journal:  Onco Targets Ther       Date:  2020-03-23       Impact factor: 4.147

4.  Circ_0000267 promotes gastric cancer progression via sponging MiR-503-5p and regulating HMGA2 expression.

Authors:  Xiaopeng Cai; Jiayan Nie; Liangdong Chen; Fang Yu
Journal:  Mol Genet Genomic Med       Date:  2019-12-17       Impact factor: 2.183

5.  Upregulation of hsa_circRNA_102958 Indicates Poor Prognosis and Promotes Ovarian Cancer Progression Through miR-1205/SH2D3A Axis.

Authors:  Guan Wang; Huijing Zhang; Peiling Li
Journal:  Cancer Manag Res       Date:  2020-05-28       Impact factor: 3.989

Review 6.  Exosomal circular RNA sorting mechanisms and their function in promoting or inhibiting cancer.

Authors:  Xiuchao Geng; Xiaomeng Lin; Yuhao Zhang; Qiang Li; Yajing Guo; Chuan Fang; Hong Wang
Journal:  Oncol Lett       Date:  2020-03-06       Impact factor: 2.967

Review 7.  Functions and clinical significance of circular RNAs in glioma.

Authors:  Jikui Sun; Banban Li; Chang Shu; Quanfeng Ma; Jinhuan Wang
Journal:  Mol Cancer       Date:  2020-02-15       Impact factor: 27.401

8.  Circular RNA-0001283 Suppresses Breast Cancer Proliferation and Invasion via MiR-187/HIPK3 Axis.

Authors:  Ying Hu; Feixiang Guo; Hongquan Zhu; Xiaobin Tan; Xiansen Zhu; Xiaofeng Liu; Wei Zhang; Qiong Yang; Yaling Jiang
Journal:  Med Sci Monit       Date:  2020-02-18

9.  Circ_0000215 Increases the Expression of CXCR2 and Promoted the Progression of Glioma Cells by Sponging miR-495-3p.

Authors:  Nurehemaiti Mutalifu; Peng Du; Jingjing Zhang; Halik Akbar; Baofeng Yan; Sulaiman Alimu; Lingxiao Tong; Xinping Luan
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

10.  CircRNAs as potential biomarkers for the clinicopathology and prognosis of glioma patients: a meta-analysis.

Authors:  Xiangqian Ding; Luyao Yang; Xin Geng; Yanghong Zou; Zhigang Wang; Yao Li; Renli Qi; Wei Wang; Jinghui Li; Hualin Yu
Journal:  BMC Cancer       Date:  2020-10-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.